Taylor Floyd, Ph.D.

Taylor Floyd, Ph.D. has a diverse work experience primarily focused on bioinformatics and neuroscience. They currently work as a Bioinformatics Scientist at Envisagenics, where they utilize RNA-sequencing data and computational techniques to discover neopeptide targets for breast cancer subtypes. They also create custom scripts and collaborate with team members to build target discovery pipelines.

Before joining Envisagenics, Taylor completed a Neuroscience PhD at Weill Cornell Graduate School of Medical Sciences. Their research involved applying next-generation sequencing techniques and transcriptome analysis tools to study minor intron splicing in human health and disease. They also worked on projects related to SARS CoV 2 viral infection and cell-type-specific expression analysis using single-cell isoform RNA-Seq.

Taylor previously interned at Envisagenics, where they focused on the breast cancer neopeptide discovery project. They integrated various biological and computational techniques to identify neopeptide targets and contributed to pipeline development. They also presented their findings to the company's employees.

In addition to their scientific work, Taylor served as the President of the Tri-Institutional Minority Society (TiMS), where they led efforts to increase diversity and inclusion in the scientific community. They organized mentorship programs, events, and collaborations to promote opportunities for underrepresented groups.

During their undergraduate years, Taylor worked as a Neuroscience student at Wright State University. They also had roles as a PHR/SPHR Course Coordinator and Lead Student Assistant at the university.

Overall, Taylor Floyd, Ph.D. has a strong background in bioinformatics, neuroscience, and promoting diversity and inclusion in the scientific community.

Taylor Floyd, Ph.D. completed a Bachelor of Science (B.S.) degree in Biological and Biomedical Sciences from Wright State University, where they attended from 2011 to 2016. Following this, they pursued further education at the Weill Cornell Graduate School of Medical Sciences, where they obtained a Doctor of Philosophy (Ph.D.) degree in Neuroscience. Taylor Floyd's studies at the Weill Cornell Graduate School of Medical Sciences occurred between 2016 and 2022.